Health & Personal Care
HIGH
FDA DRUG
Quallent Pharmaceuticals Health LLC Recall Expands for Duloxetine Delayed-Release Capsules Over Imp-
CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.
DULOXETINE
CGMP deviations:
Brand hub
CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.